Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Montmorency tart cherry extract is a botanical extract derived from the fruit of the *Prunus cerasus* tree, specifically the Montmorency cultivar. It is a rich source of phytochemicals, including anthocyanins and natural melatonin, which contribute to its therapeutic profile. The extract is primarily used as a dietary supplement to improve sleep quality and duration by regulating circadian rhythms and increasing the bioavailability of tryptophan. It also exhibits potent anti-inflammatory and antioxidant properties, making it a popular choice for reducing muscle soreness and accelerating recovery following strenuous exercise. Clinical research, such as the Sip2Sleep study, has explored its efficacy in managing insomnia and anxiety, often in combination with other botanical extracts like Rafuma leaf extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on montmorency tart cherry extract.